Global Preclinical Cro Market Size & Outlook, 2026-2033
Global preclinical cro market, 2021-2033 (US$M)
Related Markets
Global preclinical cro market highlights
- The global preclinical cro market generated a revenue of USD 6,698.9 million in 2025 and is expected to reach USD 12,776.8 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 8.4% by 2033.
- In terms of segment, preclinical optimization, efficacy & pk/pd accounted for a revenue of USD 2,326.1 million in 2025.
- Early CMC / Phase I–II Supply is the most lucrative development stage segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, China is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 6,698.9 million |
| Market revenue in 2033 | USD 12,776.8 million |
| Growth rate | 8.4% (CAGR from 2026 to 2033) |
| Largest segment | Preclinical optimization, efficacy & pk/pd |
| Fastest growing segment | Early CMC / Phase I–II Supply |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Target Discovery, Preclinical Optimization, Efficacy & PK/PD, IND-Enabling Safety (GLP), Bioanalysis & Analytics, Early CMC / Phase I–II Supply |
Other key industry trends
- In terms of revenue, the North America accounted for 48.1% of the global preclinical cro market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 759.2 million by 2033.
Preclinical optimization, efficacy & pk/pd was the largest segment with a revenue share of 34.72% in 2025. Horizon Databook has segmented the Global preclinical cro market based on target discovery, preclinical optimization, efficacy & pk/pd, ind-enabling safety (glp), bioanalysis & analytics, early cmc / phase i–ii supply covering the revenue growth of each sub-segment from 2021 to 2033.
The geographical distribution of R&D activities is slowly shifting from developed nations to emerging countries. Rising R&D expenditure coupled with an increase in failure rates of R&D activities has caused biopharmaceutical companies to prefer regions such as Central and Eastern Europe, Asia Pacific, and Latin America & Middle East for ensuring cost saving and quick patient recruitment.
Outsourcing of preclinical trials to regions such as Asia Pacific also provides greater economic benefits to biopharmaceutical companies. Governments of countries such as Singapore and China are allocating funds to promote biomedical research in this region.
Besides, as a large number of clinical trials are being conducted in countries of Asia Pacific and Latin America regions, preclinical trials are also expected to follow the same trend. This would allow preclinical testing to be conducted in close proximity to central development centers conducting clinical trials.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Preclinical CRO Market Scope
Preclinical CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| SGA | View profile | 11-50 | Las Condes, Region Metropolitana, Chile, South America | https://sgasa.cl |
| Crown Bioscience | View profile | 251-500 | Santa Clara, California, United States, North America | http://www.crownbio.com |
| Intertek Group PLC | View profile | 44000 | 33 Cavendish Square, London, United Kingdom, W1G 0PS | https://www.intertek.com |
| Medpace Holdings Inc | View profile | 5800 | 5375 Medpace Way, Cincinnati, OH, United States, 45227 | https://www.medpace.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Global preclinical cro market size, by regions, 2021-2033 (US$M)
Top 10 countries: Preclinical cro market size, 2025 (US$M)
Global preclinical cro market share, by service, 2025 & 2033 (%, US$M)
Preclinical cro market: Opportunity assessment by country
Global preclinical cro market, by region, 2025 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
